References
- Ramos-Remus C, Sibley J, Russell A S. Steroids in rheumatoid arthritis: The honeymoon revisited. J Rheumatol 1992; 19: 5: 667–70
- Kennedv A C, Smith D A, Buchanan J B, Anderson J B, Jasani M K. Bone loss in patients with rheumatoid arthritis. Scand J Rheumatol 1975; 4: 73–9
- Sambrook P N, Eisman J A, Yeates M G, Pocock N A, Eberl S, Champion G D. Osteoporosis in rheumatoid arthritis: safety of low dose corticosteroids. Ann Rheum Dis 1986; 45: 950–3
- Michel B A, Bloch D A, Fries J A. Predictors of fractures in early rheumatoid arthritis. J Rheumatol 1991; 18: 804–8
- Butler R C, Davie M WJ, Worsfold M, Sharp C A. Bone mineral content in patients with rheumatoid arthritis: relationship to low dose steroid therapy. Brit J Rheumatol 1991; 30: 86–90
- Gluck O S, Murphy W A, Hahn T J, Hahn B. Bone loss in adults receiving alternate day corticosteroid therapy. Arthritis Rheum 1981; 24(7)892–8
- Sambrook P N, Eisman J A, Champion G D, Yates M G, Eberl S. Determinants of axial bone loss in rheumatoid arthritis. Arthitis Rheum 1987; 30: 721–8
- Kovarsky J, Pegram S B. Bolus intramuscular methylpredniso-lone acetate as a therapeutic adjunct in rheumatoid arthritis. Southern Med J 1986; 79(12)1521–3
- Corkill M M, Kirkham B W, Chikanza I C, Gibson, Panayi G S. Intramuscular depot methylprednisolone induction of chrysoth-erapy in rheumatoid arthritis: a 24 week randomized controlled trial. Brit J Rheumatol 1990; 29: 274–9
- Byron M A, Mowat A G. Corticosteroid prescribing in rheumatoid arthritis - the fiction and the fact. Brit J Rheumatol 1985; 24: 164–6